Rtw Biotech Regulatory News (RTW)

For

98,914,920 votes

Against

 0 votes

Withheld

 683,747 votes

For

98,849,112 votes

Against

29,808 votes

Withheld

719,747 votes

For

311,299,748 votes

Against

2,978 votes

Withheld

685,079 votes

For

311,301,247 votes

Against

2,811 votes

Withheld

683,747 votes

For

311,301,247 votes

Against

2,811 votes

Withheld

683,747 votes

For

98,912,109 votes

Against

2,811 votes

Withheld

683,747 votes

For

98,897,191 votes

Against

17,729 votes

Withheld

683,747 votes

For

98,910,777 votes

Against

4,143 votes

Withheld

683,747 votes

Resolution 9

IT WAS RESOLVED That the Company be and is hereby authorised, in accordance with section 315 of the Companies (Guernsey) Law, 2008, as amended (the "Companies Law"), subject to the Listing Rules made by the United Kingdom Financial Conduct Authority and all other applicable legislation and regulations, to make market acquisitions (within the meaning of section 316 of the Companies Law) of its own Ordinary Shares (as defined in the Company's Articles) which may be cancelled or held as treasury shares, provided that:

i. the maximum number of Ordinary Shares authorised to be purchased under this authority shall be 31,837,132 Ordinary Shares (being 14.99 per cent. of the Ordinary Shares in issue as at the Latest Practicable Date, excluding any treasury shares);

ii. the minimum price (exclusive of expenses) which may be paid for an Ordinary Share is US$0.01;

iii. the maximum price (exclusive of expenses) which may be paid for an Ordinary Share shall be not more than an amount equal to the higher of (a) 5 per cent. above the average mid-market value of the Ordinary Shares on the regulated market where the repurchase is carried out for the five Business Days (as defined in the Company's Articles) prior to the day the purchase is made and (b) the higher of (i) the price of the last independent trade and (ii) the highest current independent bid price, in each case on the regulated market where the purchase is carried out; and

such authority to expire on the date which is 15 months from the date of passing of this resolution or, if earlier, at the end of the Annual General Meeting of the Company to be held in 2023 (unless previously renewed, revoked or varied by the Company by ordinary resolution), save that the Company may make a contract to acquire Ordinary Shares under this authority before its expiry which will or may be executed wholly or partly after its expiration and the Company may make an acquisition of Ordinary Shares pursuant to such a contract.

Resolution 10

IT WAS RESOLVED  That the maximum annual amount of remuneration available to be paid to all Directors under the Company's Articles, in aggregate, is increased by US$200,000, from US$300,000 per annum to US$500,000 per annum (or the applicable currency equivalent thereof).

Responses to investor's questions will be posted on the Company's website after the AGM.

¹ The Company notes that the voting rights adjustments under Article 6 and Article 23 of the Company's Articles of Incorporation were used in respect of resolutions 3, 4, and 5, but this did not affect the outcome of the shareholder vote.

RTW Investments, LP

+1 (646) 343 9280

Stephanie Sirota, Chief Business Officer

Woody Stileman, Managing Director, Strategic Partnerships

Elysium Fund Management Limited

+44 (0) 14 8181 0100

Joanna Duquemin Nicolle, Chief Executive Officer

Sadie Morrison, Managing Director

J.P. Morgan Cazenove

+44 (0)20 7742 4000

William Simmonds

Jérémie Birnbaum

James Bouverat (Sales)

BofA Securities

+44 (0) 20 7628 1000

Edward Peel

Kieran Millar